Unnecessary thyroid surgery rate for suspicious nodule in the absence of molecular testing
Authors' conclusion
In this real data cohort surgery was unnecessary in more than half of patients with Bethesda III and IV nodules and in 21% of patients with Bethesda V nodules.
Study context
- Population
- Consecutive patients undergoing fine needle aspiration cytology (FNAC) with rapid on-site evaluation, January 2017–December 2021; 640 females, mean age 54.2 years; 1010 nodules (median size 24.4 mm), 1189 FNAC1,010 nodules
- Participants
- 862 patients
- Exposure
- Bethesda III vs Bethesda IV vs Bethesda V
- Outcome
- Rate of unnecessary surgery (surgery for Bethesda III, IV or V results without local compressive symptoms with final benign pathology, and second surgery for completion thyroidectomy) in the absence of molecular testing
Methodological detailssingle-centre, consecutive patients
- Single-centre
- Consecutive patients
Main finding
As reported in the abstract
Unnecessary surgery
Observational data: associations, not effects.
Further findings
Surgery performed (benign on pathology)
Benign on pathology
FNAC Bethesda category distribution
- Bethesda I, II, III, IV, V, VI
- 8%, 48%, 17%, 17%, 3%, 6%
EU-TIRADS distribution of nodules
- EU-TIRADS 2, 3, 4, 5
- 3%, 34%, 42%, 22%
Original publication
Unnecessary thyroid surgery rate for suspicious nodule in the absence of molecular testing. Eur Thyroid J. Published 11 October 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →